MedPath
HSA Approval

ONDA SOLUTION FOR INJECTION 2mg/ml

SIN15929P

ONDA SOLUTION FOR INJECTION 2mg/ml

ONDA SOLUTION FOR INJECTION 2mg/ml

April 13, 2020

TRANET HOLDINGS PTE LTD

TRANET HOLDINGS PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantTRANET HOLDINGS PTE LTD
Licence HolderTRANET HOLDINGS PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAVENOUS

Medical Information

A04AA01

ondansetron

Manufacturer Information

TRANET HOLDINGS PTE. LTD.

VIANEX SA(METAMORPHOSSI PRODUCTION SITE)

Active Ingredients

ONDANSETRON HCL DIHYDRATE EQ TO ONDANSETRON

2.00mg/ml

Ondansetron

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ONDA SOLUTION FOR INJECTION 2mg/ml - HSA Approval | MedPath